From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Asymptomatic Mitral Regurgitation: When Is Surgery Indicated?

Patients with regurgitant orifices ≥40 mm2 should be considered for prompt surgery.

Asymptomatic mitral regurgitation (MR) presents a dilemma: We'd like to avoid surgery in asymptomatic patients, but outcomes might be worse if we wait for heart failure to occur. This prospective observational study from Mayo Clinic provides some guidance.

Researchers followed 456 patients (mean age, 63) with initially asymptomatic primary MR due to diseased valve leaflets (as opposed to MR secondary to dilated cardiomyopathy or ischemia); 80% had mitral valve prolapse. Effective regurgitant orifice (determined by echocardiography) was the best predictor of adverse outcomes. Even with medical management, patients with orifices of ≥40 mm2 and those with orifices of 20 mm2 to 39 mm2 had significantly reduced 5-year survival compared with expected U.S. survival rates (58% and 66% vs. 78%). Patients with orifices of <20 mm2 had normal survival rates.

During follow-up, 230 patients underwent surgery for symptoms or progressive echocardiographic abnormalities (209 had valve repair, and 21 had valve replacement). Statistical analyses suggested that surgery normalized life expectancy, although 2 patients died from postoperative complications.

Comment: Although these patients were not randomized to surgery or no surgery, we can infer that patients with regurgitant orifices of ≥40 mm2 should be considered for prompt surgery; those with orifices of 20 mm2 to 39 mm2 should be followed closely. As editorialists note, surgery becomes more attractive when valve repair is feasible, because repair avoids some of the complications associated with valve replacement.

— Allan S. Brett, MD

Published in Journal Watch General Medicine March 15, 2005

Citation(s):

Enriquez-Sarano M et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005 Mar 3; 352:875-83.

Otto CM and Salerno CT. Timing of surgery in asymptomatic mitral regurgitation. N Engl J Med 2005 Mar 3; 352:928-9.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2005. Massachusetts Medical Society. All rights reserved.